STOCK TITAN

[Form 4] Doximity, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Benjamin Regina M., a director of Doximity, Inc. (DOCS), received a grant of 3,221 restricted stock units (RSUs) on 08/28/2025 under the issuer's non-employee director compensation policy. Each RSU represents a contingent right to one share of Class A common stock and the grant was reported with a transaction price of $0. The RSUs vest in full on the earlier of the first anniversary of the grant date or the issuer's next annual meeting of stockholders, subject to the reporting person's continued service as a director through the applicable vesting date. After the grant, the reporting person beneficially owned 19,839 shares of Class A common stock on a direct basis. The Form 4 was signed on behalf of the reporting person by an attorney-in-fact on 09/02/2025.

Benjamin Regina M., membro del consiglio di amministrazione di Doximity, Inc. (DOCS), ha ricevuto in data 28/08/2025 una concessione di 3.221 unità azionarie vincolate (RSU) ai sensi della politica di compensazione per amministratori non esecutivi dell'emittente. Ciascuna RSU dà diritto condizionato a una azione di Class A common stock e la transazione è stata riportata con prezzo di $0. Le RSU maturano integralmente alla prima tra il primo anniversario della data di concessione e la successiva assemblea annuale degli azionisti dell'emittente, subordinatamente alla permanenza in carica del soggetto che segnala fino alla data di maturazione applicabile. Dopo la concessione, il soggetto che segnala deteneva direttamente 19.839 azioni di Class A common stock. Il Modulo 4 è stato firmato per conto del dichiarante da un procuratore il 02/09/2025.

Benjamin Regina M., director de Doximity, Inc. (DOCS), recibió el 28/08/2025 una adjudicación de 3.221 unidades restringidas de acciones (RSU) conforme a la política de compensación para directores no empleados del emisor. Cada RSU confiere un derecho contingente a una acción de Class A common stock y la operación se reportó con un precio de $0. Las RSU se consolidan en su totalidad a la primera de las siguientes fechas: el primer aniversario de la concesión o la próxima junta anual de accionistas del emisor, sujeto a que el declarante continúe en su cargo de director hasta la fecha de consolidación aplicable. Tras la adjudicación, el declarante poseía directamente 19.839 acciones de Class A common stock. El Formulario 4 fue firmado en nombre del declarante por un apoderado el 02/09/2025.

Benjamin Regina M.는 Doximity, Inc. (DOCS)의 이사로서 2025-08-28에 발행인의 비임원 이사회 보상 정책에 따라 3,221 제한 주식 단위(RSU)를 부여받았습니다. 각 RSU는 Class A 보통주의 1주에 대한 조건부 권리를 의미하며, 해당 부여는 거래 가격 $0로 보고되었습니다. RSU는 부여일의 첫 번째 기념일 또는 발행인의 다음 연례 주주총회 중 빠른 시점에 전부 확정되며, 이는 보고인이 해당 확정일까지 이사로서 계속 재직하는 것을 조건으로 합니다. 부여 후 보고인은 직접적으로 19,839주의 Class A 보통주를 보유하고 있었습니다. Form 4는 2025-09-02에 보고인을 대신해 대리인이 서명했습니다.

Benjamin Regina M., administrateur de Doximity, Inc. (DOCS), a reçu le 28/08/2025 une attribution de 3 221 unités d'actions restreintes (RSU) dans le cadre de la politique de rémunération des administrateurs non salariés de l'émetteur. Chaque RSU représente un droit conditionnel à une action de Class A common stock et l'attribution a été déclarée avec un prix de transaction de 0 $. Les RSU deviennent pleinement acquises à la première des deux dates suivantes : l'anniversaire de la date d'attribution ou la prochaine assemblée générale annuelle des actionnaires de l'émetteur, sous réserve que la personne déclarante reste en fonction en tant qu'administrateur jusqu'à la date d'acquisition applicable. Après l'attribution, la personne déclarante détenait directement 19 839 actions de Class A common stock. Le formulaire 4 a été signé au nom de la personne déclarante par un mandataire le 02/09/2025.

Benjamin Regina M., Direktor von Doximity, Inc. (DOCS), erhielt am 28.08.2025 eine Zuteilung von 3.221 Restricted Stock Units (RSUs) im Rahmen der Vergütungsrichtlinie des Emittenten für nicht-geschäftsführende Direktoren. Jede RSU stellt ein bedingtes Recht auf eine Aktie der Class A common stock dar, und die Zuteilung wurde mit einem Transaktionspreis von $0 gemeldet. Die RSUs werden vollständig fällig am früheren der beiden Zeitpunkte: dem ersten Jahrestag des Zuteilungsdatums oder der nächsten Jahreshauptversammlung des Emittenten, vorbehaltlich der fortgesetzten Tätigkeit der meldenden Person als Direktor bis zum jeweiligen Fälligkeitsdatum. Nach der Zuteilung hielt die meldende Person direkt 19.839 Aktien der Class A common stock. Das Formular 4 wurde am 02.09.2025 im Namen der meldenden Person von einem Bevollmächtigten unterschrieben.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Routine director compensation grant with near-term vesting ties pay to continued board service.

This RSU award to a non-employee director follows standard corporate practice of using equity to align outside directors with shareholder interests. The vesting schedule — full vesting at the earlier of one year or the next annual meeting — creates a clear service condition rather than performance contingencies. The report shows direct beneficial ownership of 19,839 Class A shares after the grant, which updates insider holdings transparency. There are no disclosed special acceleration provisions or cash purchase, and the transaction was reported under Form 4 rules.

TL;DR: Non-material equity grant from an investor-impact perspective; standard disclosure of insider holdings.

The Form 4 documents a grant of 3,221 RSUs at $0 per unit to a director, increasing reported direct beneficial ownership to 19,839 Class A shares. For investors, this is a routine compensation disclosure rather than a corporate event expected to materially affect valuation or operations. The filing provides clear vesting terms and the grant date, satisfying Section 16 reporting requirements. No derivative positions, exercises, or sales are reported.

Benjamin Regina M., membro del consiglio di amministrazione di Doximity, Inc. (DOCS), ha ricevuto in data 28/08/2025 una concessione di 3.221 unità azionarie vincolate (RSU) ai sensi della politica di compensazione per amministratori non esecutivi dell'emittente. Ciascuna RSU dà diritto condizionato a una azione di Class A common stock e la transazione è stata riportata con prezzo di $0. Le RSU maturano integralmente alla prima tra il primo anniversario della data di concessione e la successiva assemblea annuale degli azionisti dell'emittente, subordinatamente alla permanenza in carica del soggetto che segnala fino alla data di maturazione applicabile. Dopo la concessione, il soggetto che segnala deteneva direttamente 19.839 azioni di Class A common stock. Il Modulo 4 è stato firmato per conto del dichiarante da un procuratore il 02/09/2025.

Benjamin Regina M., director de Doximity, Inc. (DOCS), recibió el 28/08/2025 una adjudicación de 3.221 unidades restringidas de acciones (RSU) conforme a la política de compensación para directores no empleados del emisor. Cada RSU confiere un derecho contingente a una acción de Class A common stock y la operación se reportó con un precio de $0. Las RSU se consolidan en su totalidad a la primera de las siguientes fechas: el primer aniversario de la concesión o la próxima junta anual de accionistas del emisor, sujeto a que el declarante continúe en su cargo de director hasta la fecha de consolidación aplicable. Tras la adjudicación, el declarante poseía directamente 19.839 acciones de Class A common stock. El Formulario 4 fue firmado en nombre del declarante por un apoderado el 02/09/2025.

Benjamin Regina M.는 Doximity, Inc. (DOCS)의 이사로서 2025-08-28에 발행인의 비임원 이사회 보상 정책에 따라 3,221 제한 주식 단위(RSU)를 부여받았습니다. 각 RSU는 Class A 보통주의 1주에 대한 조건부 권리를 의미하며, 해당 부여는 거래 가격 $0로 보고되었습니다. RSU는 부여일의 첫 번째 기념일 또는 발행인의 다음 연례 주주총회 중 빠른 시점에 전부 확정되며, 이는 보고인이 해당 확정일까지 이사로서 계속 재직하는 것을 조건으로 합니다. 부여 후 보고인은 직접적으로 19,839주의 Class A 보통주를 보유하고 있었습니다. Form 4는 2025-09-02에 보고인을 대신해 대리인이 서명했습니다.

Benjamin Regina M., administrateur de Doximity, Inc. (DOCS), a reçu le 28/08/2025 une attribution de 3 221 unités d'actions restreintes (RSU) dans le cadre de la politique de rémunération des administrateurs non salariés de l'émetteur. Chaque RSU représente un droit conditionnel à une action de Class A common stock et l'attribution a été déclarée avec un prix de transaction de 0 $. Les RSU deviennent pleinement acquises à la première des deux dates suivantes : l'anniversaire de la date d'attribution ou la prochaine assemblée générale annuelle des actionnaires de l'émetteur, sous réserve que la personne déclarante reste en fonction en tant qu'administrateur jusqu'à la date d'acquisition applicable. Après l'attribution, la personne déclarante détenait directement 19 839 actions de Class A common stock. Le formulaire 4 a été signé au nom de la personne déclarante par un mandataire le 02/09/2025.

Benjamin Regina M., Direktor von Doximity, Inc. (DOCS), erhielt am 28.08.2025 eine Zuteilung von 3.221 Restricted Stock Units (RSUs) im Rahmen der Vergütungsrichtlinie des Emittenten für nicht-geschäftsführende Direktoren. Jede RSU stellt ein bedingtes Recht auf eine Aktie der Class A common stock dar, und die Zuteilung wurde mit einem Transaktionspreis von $0 gemeldet. Die RSUs werden vollständig fällig am früheren der beiden Zeitpunkte: dem ersten Jahrestag des Zuteilungsdatums oder der nächsten Jahreshauptversammlung des Emittenten, vorbehaltlich der fortgesetzten Tätigkeit der meldenden Person als Direktor bis zum jeweiligen Fälligkeitsdatum. Nach der Zuteilung hielt die meldende Person direkt 19.839 Aktien der Class A common stock. Das Formular 4 wurde am 02.09.2025 im Namen der meldenden Person von einem Bevollmächtigten unterschrieben.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Benjamin Regina M.

(Last) (First) (Middle)
C/O DOXIMITY, INC.
500 THIRD STREET

(Street)
SAN FRANCISCO CA 94107

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Doximity, Inc. [ DOCS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/28/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 08/28/2025 A 3,221(1) A $0 19,839 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. These shares represent restricted stock units (each, an "RSU") granted on August 28, 2025 pursuant to the Issuer's non-employee director compensation policy, which vest in full on the earlier of (i) the first anniversary of the grant date or (ii) the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service as a director through the applicable vesting date. Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock.
Remarks:
/s/ Anna Bryson, Attorney-in-Fact 09/02/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did DOCS director Benjamin Regina M. receive on 08/28/2025?

The director received 3,221 restricted stock units (RSUs), each representing a contingent right to one share of Class A common stock.

When do the RSUs granted to Benjamin Regina M. vest?

The RSUs vest in full on the earlier of (i) the first anniversary of the grant date or (ii) Doximity's next annual meeting of stockholders, subject to continued service.

How many Class A shares did the reporting person beneficially own after the grant?

Following the reported transaction, the reporting person beneficially owned 19,839 shares of Class A common stock on a direct basis.

Was there any cash price for the RSU grant reported?

The transaction is reported with a price of $0 for the RSU grant.

Who signed the Form 4 and when was it filed?

The Form 4 was signed on behalf of the reporting person by an attorney-in-fact on 09/02/2025.
Doximity Inc

NYSE:DOCS

DOCS Rankings

DOCS Latest News

DOCS Latest SEC Filings

DOCS Stock Data

12.83B
133.28M
2.28%
93.59%
2.17%
Health Information Services
Services-computer Programming Services
Link
United States
SAN FRANCISCO